Login/Sign Up
Tepmetko 225 mg Tablet is primarily used to treat lung cancer. It contains Tepotinib. It works by blocking the abnormal protein, which can cause uncontrolled cell growth and cancer; thus, it slows or stops cancer growth. Tepmetko 225 mg Tablet can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant or get pregnant while undergoing therapy and for several months after the treatment. Using effective contraceptive methods is recommended while on therapy. Contact your doctor immediately if you or your partner becomes pregnant while undergoing therapy.
₹137546.1*
MRP ₹152829
10% off
₹137546.1*
MRP ₹152829
10% CB
₹15282.9 cashback(10%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
About Tepmetko 225 mg Tablet
Tepmetko 225 mg Tablet belongs to a class of protein kinase inhibitors primarily used to manage or treat lung cancer that has progressed to other body regions or cannot be removed surgically. Lung cancer is a disease that causes malignant (cancer) cells to grow in lung tissues.
Tepmetko 225 mg Tablet contains Tepotinib. It works by blocking the abnormal protein, which can cause uncontrolled cell growth and cancer; thus, it slows or stops cancer growth.
To treat your condition effectually, continue using Tepmetko 225 mg Tablet for as long as your doctor has prescribed it. The most common adverse reactions are oedema (swelling), fatigue (tiredness), diarrhoea, musculoskeletal pain, dyspnea (shortness of breath), feeling sick (nausea), being sick (vomiting), diarrhoea and QT prolongation. You should talk to your doctor if you persistently experience these side effects.
Inform your doctor if you are allergic to it or have ILD (Interstitial lung disease)/pneumonitis (inflammation in your lung tissues without an infection). Tepmetko 225 mg Tablet can cause fetal harm when administered to a pregnant woman. It is critical not to become pregnant or get pregnant while undergoing therapy and for several months after the treatment. Using effective contraceptive methods is recommended while on therapy with Tepmetko 225 mg Tablet . Contact your doctor immediately if you or your partner becomes pregnant while undergoing therapy. Breastfeeding is usually not advised during this treatment since it is unknown whether this medication passes into breast milk. Alcohol should be avoided during treatment with this medicine. Safety and effectiveness in children have not been established.
Uses of Tepmetko 225 mg Tablet
Medicinal Benefits
Tepmetko 225 mg Tablet contains Tepotinib, which belongs to a class of protein kinase inhibitors primarily used to manage or treat adults with lung cancer that has progressed to other regions of the body or cannot be removed surgically. It works by blocking the abnormal protein, which can cause uncontrolled cell growth and cancer; thus, it slows or stops cancer growth.
Side Effects of Tepmetko 225 mg Tablet
Directions for Use
Drug Warnings
Before taking the Tepmetko 225 mg Tablet , inform your doctor about all your medical conditions, sensitivities, and medications you are using. If you are a woman capable of having children, you should use an effective method of contraception during Tepotinib treatment and for at least one week after the last dose. If you are a man, you should use a barrier method of contraception to prevent your partner from becoming pregnant while taking Tepotinib and for at least one week after the last dose. Do not use any other medicine, including herbal or vitamin supplements, unless the doctor suggests.
Therapeutic Class
Diet & Lifestyle Advise
Habit Forming
How Tepmetko 225 mg Tablet Works
What if I have taken an overdose of Tepmetko 225 mg Tablet
Alcohol
Caution
Avoid alcohol consumption while on treatment with Tepmetko 225 mg Tablet .
Pregnancy
Unsafe
Tepmetko 225 mg Tablet should not be used during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception to prevent pregnancy while taking these medications.
Breast Feeding
Caution
Tepmetko 225 mg Tablet should not be used in breastfeeding. Discuss with your doctor if you have any concerns.
Driving
Caution
Tepmetko 225 mg Tablet does not influence the ability to drive or use machines. However, go only if you are alert, as the Tepmetko 225 mg Tablet may cause weakness or tiredness in some people.
Liver
Caution
Tepmetko 225 mg Tablet should be used with caution if you have liver disease. Inform your doctor before taking the Tepmetko 225 mg Tablet if you have had a liver impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Kidney
Caution
Tepmetko 225 mg Tablet should be used with caution if you have kidney disease. Inform your doctor before taking the Tepmetko 225 mg Tablet if you have had a kidney impairment/disorder history. Your doctor will prescribe only if the benefits outweigh the risks.
Children
Unsafe
Safety and effectiveness in patients below the age of 18 years have not been established. Hence, use is not recommended.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information